National Institutes of Neurological Disorders and Stroke

Stem cell research concerning neurological disorders

The National Institutes of Neurological Disorders and Stroke (NINDS) belong to the National Institute of Health.

In 1950, the National Institute of Neurological Diseases and Blindness (NINDB) was authorized.

18 years later, the institute’s name changed to the National Institute of Neurological Disoders and Stroke (NINDS) and the National Eye Institute became a separate research centre.

Story C. Landis, Ph.D., Director
Audrey S. Penn, M.D., Deputy Director
Joellen Harper Austin, Acting Executive Officer

NIH Neurological Institute
P.O. Box 5801
Bethesda, MD 20824
USA
Phone: +1-301-496-5751

The NINDS focuses on basic and clinical research of brain and nervous system disorders such as Parkinson’s, Alzheimer’s and demyelinating disease, as well as their understanding in general and changing in specific diseases to offer their detection, prevention and treatment.

The NINDS aims to develop new drugs and adequate therapies such as stem cell implants and gene transfer in order to treat patients suffering from those diseases.

Aspects of the basic research programme are i.a. biology of the cells of the nervous system, brain and nervous system development, genetics of the brain, cognition and behavior, neurodegeneration, brain plasticity and repair.